Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

AstraZeneca

Status: Completed

Conditions: GERD

Study type: Observational

Funder types: Industry

Identifiers

NCT00884247

NIS-GSE-DUM-2009/1

Details and patient eligibility

About

The study aims to evaluate if a GERD treatment programme, in accordance with current regional recommendations, in a company health care setting, has an impact on health related quality of life (HRQoL), symptoms, and productivity in GERD patients.

Enrollment: 36 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female and/or male aged > 18 years
• Diagnosis of GERD confirmed
• Prescription of GERD treatment or already receiving GERD treatment

Exclusion criteria

• Any symptom suggesting a need for further investigation
• Previous participation in the present study
• Current participation in a clinical study or participation in a clinical study during the last 30 days